логотип

Version for the visually impaired

+7(7172) 70-80-90
+7 702 006 56 56

Galiya Tussupbekova

PROFILE:

  • Allergology - Immunology

MAIN DIRECTIONS OF WORK:

  • Provision of specialized allergology and immunological medical care for attached contingent, as well as self-paid patients and in insurable events on a contractual basis
  • Examination and treatment of children with allergic and immune-dependent diseases on a paid basis
  • Conducting diagnostics of allergic diseases with skin tests (application, scarification, intradermal, prick and patch tests), laboratory studies for determining common allergy biomarkers and specific IgE to allergens on ImmunoCAP250 analyzers and by immunoblotting (EUROIMMUN)
  • Desensitizing therapy in day and round-the-clock patient facilities for acute allergoses and exacerbations of chronic allergic diseases
  • Conducting preventive allergen-specific immunotherapy as pathogenetic basic treatment of allergic diseases
  • Preparing patients with high risk of anaphylaxis to highly invasive examinations and surgical interventions
  • Training residents in allergology-immunology
  • Conducting and participating in consultations, scientific and practical conferences
  • Publications in scientific journals, participation in research projects

EXPERIENCE:

  • 2022 - present    Chief Allergist - Immunologist of Allergy Service, Head of Allergy Center, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
  • 2019-2022    Head of Allergy Center, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan     
  • 2017-2019 Head of Department # 2, Special Service, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan     
  • 2014 Director of Astana Association of Allergology and Clinical Immunology (branch of Republican Association)
  • 2009-2017 - Head of Paid Services Department with Allergy Center, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
  • 2005 - 2019, Chief Consulting Allergist of Astana Health Department
  • 2001 2008 Allergist-Immunologist, Senior Researcher, National Scientific Medical Center        
  • 1992-2001 Allergist - Immunologist, Karaganda Interregional Diagnostic Center with inpatient beds. Part-time General Practitioner
  • 1989 -1992 - Central District Hospital, General practitioner, Agadyr, Karaganda region
  • 1988-1989 Intern, Balkhash Central City Hospital

EDUCATION:

  • 1982-1988 General Medicine, Karaganda State Medical Institute

MEMBERSHIPS:

  • Member of Kazakhstan Association of Allergology and Clinical Immunology
  • Member of European Academy of Allergy and Clinical Immunology
  • Member of European Respiratory Society

PUBLICATIONS:

  • Article: Introduction of Omalizumab in treatment of chronic spontaneous urticaria, G.M. Tussupbekova, Herald # 4 (77) 2019
  • Article: Assessment of quality of life in chronic urticaria, B.M. Davletova, G.M. Tussupbekova, A.A.Syzdykova, Herald # 1 (78) 2020
  • Article: Case of atopic dermatitis with severe resistant course in an adult patient with atopic march, G.M. Tussupbekova, A.A. Syzdykova, B.M. Davletova, Russian Journal of Allergy, Volume 17, # 2, 2020 with impact factor
  • Thesis, poster report: The first experience of using dupilumab in severe atopic dermatitis in Kazakhstan, G.M. Tussupbekova ., Hybrid Congress of the European Academy of Allergy and Clinical Immunology, July, 2022, Prague
  • Article: Experience of using omalizumab in patients with chronic spontaneous urticaria with severe refractory course, G.M. Tussupbekova, Herald # 1, 2023
  • Thesis, poster report: Kazakhstan's experience in use of omalizumab in the treatment of chronic spontaneous urticaria, G.M. Tussupbekova, Digital Congress of the European Academy of Allergology and Clinical Immunology (June 4-6, 2020), London, platform 176
  • Thesis, poster report: Results of using omalizumab in treatment of chronic spontaneous urticaria associated with autoimmune thyroiditis, G.M Tussupbekova, Hybrid Congress of the European Academy of Allergology and Clinical Immunology, July 2021, Krakow
  • Thesis, poster report: Experience in treatment of severe bronchial asthma with omalizumab in combination with severe vernal keratoconjunctivitis, G.M.Tussupbekova, Hybrid Congress of the European Academy of Allergology and Clinical Immunology, July 2023, Hamburg

AWARDS:

  • Medal "For Distinguished Labour"
  • Award pin "For contribution to development of healthcare"
  • Medal "20th anniversary of the Assembly of People of Kazakhstan"
  • Medal "25th anniversary of Independence of the Republic of Kazakhstan"
  • Certificates of Merit

Hospital Partners